Compass Therapeutics Q1 2026 Earnings Narrowerthanexpected Loss Fuels Investor Optimism FSBW Q1 2026 Earnings Modest EPS Beat Highlights Stability Amid Soft Stock Response Investors Title Company ITIC Q4 2025 Earnings Strong EPS Performance Amid Limited Visibility WDAY Q1 2026 Earnings EPS Beats Estimates by 40 Shares Rise FCBC Q1 2026 Earnings Slight EPS Miss Amid Flat Revenue Stock Inches Higher BioLineRx Ltd BLRX Q3 2024 Earnings Narrowed Loss and Strategic Progress